Evidence map›Paper›PMID 40690044›Full record

ArticleInternational ophthalmology2025

Patients' awareness and presenting symptoms at the onset of neovascular age-related macular degeneration in two distinct European cohorts.

Celeste Limoli, Louise O'Toole, Gabriele Piccoli, Paolo Nucci, Stela Vujosevic

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Celeste LimoliEye Clinic, IRCCS MultiMedica, Milan, Italy.
Louise O'TooleDepartment of Ophthalmology, Bon Secours Hospital Dublin, Dublin, Ireland.
Gabriele PiccoliEye Clinic, IRCCS MultiMedica, Milan, Italy.
Paolo NucciDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Eye Clinic, IRCCS MultiMedica, Via San Vittore 12, 20123, Milan, Italy.
Stela VujosevicEye Clinic, IRCCS MultiMedica, Milan, Italy. stela.vujosevic@unimi.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNeovascular age-related macular degeneration (nAMD) is a common ocular condition in the elderly population. If left untreated, it can lead to significant visual impairment. Prompt detection of the disease achieves better therapeutic outcomes. The goal of this study is to ascertain the presenting symptoms of nAMD from two different population groups.

methodsA questionnaire was distributed to two groups of patients with nAMD who attended intravitreal injection services in Milan and Dublin. Four age-subgroups were considered: 60-69, 70-79, 80-89, > 90 years. Patients completed an interview questionnaire regarding their symptoms at the time of diagnosis with nAMD. The patients were divided into two groups; Group A consisted of Italian patients and group B comprised Irish patients. Symptom differences between the groups were compared using the Chi-square test.

resultsA total of 237 patients with nAMD were included in the study, with 136 in group A and 101 in group B. The most common age-subgroup was 80-89 years (49.8%); the majority 129(54.4%) patients were females. The most frequently reported symptom at the time of nAMD onset was distortion (n = 105, 44.3%). Notably, 50 patients (21.1%) were asymptomatic. The Irish patients were less aware of the onset of the symptoms of nAMD compared with their Italian counterparts(p < 0.001).

conclusionThis study shows that 21.1% of patients with nAMD were asymptomatic at the onset of their condition. Symptom awareness was higher among the Italian cohort compared to the Irish group. Patients at risk for conversion to nAMD should attend regular OCT monitoring rather than relying on subjective symptoms alone.

Indexed as

AwarenessVisual AcuityWet Macular DegenerationAgedAged, 80 and overAngiogenesis InhibitorsFemaleFluorescein AngiographyHumansIntravitreal InjectionsIrelandItalyMaleMiddle AgedSurveys and QuestionnairesTomography, Optical CoherenceAngiogenesis InhibitorsColoradoDenverNeovascular age-related macular degenerationPartially presented at the ARVO 2022 Annual MeetingRetinal imagingSelf-monitoringSymptom awareness

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.